CoChat

In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride

Narendran, Rajesh, Hwang, Dah‐Ren, Slifstein, Mark, Talbot, Peter S., Erritzoe, David, Huang, Yiyun, Cooper, Thomas B., Martinez, Diana, Kegeles, Lawrence S., Abi‐Dargham, Anissa, Laruelle, Marc · 2004 · Synapse
Cited by 157

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

(–)‐N‐Propyl‐norapomorphine (NPA) is a full dopamine (DA) D 2 receptor agonist and [11 C]NPA is a suitable radiotracer to image D 2 receptors configured in a state of high affinity for agonists with positron emission tomography (PET). In this study the vulnerability of the in vivo binding of [11 C]NPA to acute fluctuation in synaptic DA was assessed with PET in baboons and compared to that of the reference D 2 receptor antagonist radiotracer [11 C]raclopride. Three male baboons were studied with [11 C]raclopride and [11 C]NPA under baseline conditions and following administration of the potent DA releaser amphetamine (0.3, 0.5, and 1.0 mg kg–1 i.v.). Kinetic modeling with an arterial input function was used to derive the striatal specific‐to‐nonspecific equilibrium partition coefficient (V 3″). [11 C]Raclopride V 3″ was reduced by 24 ± 10%, 32 ± 6%, and 44 ± 9% following amphetamine doses of 0.3, 0.5, and 1.0 mg kg–1, respectively. [11 C]NPA V 3″ was reduced by 32 ± 2%, 45 ± 3%, and 53 ± 9% following amphetamine doses of 0.3, 0.5, and 1.0 mg kg–1, respectively. Thus, endogenous DA was more effective at competing with [11 C]NPA binding compared to [11 C]raclopride binding, a finding consistent with the pharmacology of these tracers (agonist vs. antagonist). These results also suggest that 71% of D 2 receptors are configured in a state of high affinity for agonists in vivo. In conclusion, [11 C]NPA might provide a superior radiotracer to probe presynaptic DA function with PET in health and disease. Synapse 52:188–208, 2004. © 2004 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/syn.20013

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 157

Metadata

Authors
Narendran, R., Hwang, D., Slifstein, M., Talbot, P. S., Erritzoe, D., Huang, Y., Cooper, T. B., Martinez, D., Kegeles, L. S., Abi‐Dargham, A., & Laruelle, M.
Venue
Synapse
Publisher
Wiley
Published
2004-03-25
Volume
52
Issue
3
Pages
188-208
ISSN
  • 0887-4476 (ISSN-L)
  • 1098-2396
OpenAlex
W2016678309
Cited by
157
References
11
FWCI
4.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride. https://app.cochat.ai/papers/10.1002/syn.20013
The paper
Narendran, R., Hwang, D., Slifstein, M., Talbot, P. S., Erritzoe, D., Huang, Y., Cooper, T. B., Martinez, D., Kegeles, L. S., Abi‐Dargham, A., & Laruelle, M. (2004). In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride. Synapse. https://doi.org/10.1002/syn.20013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.